The DOI matches its Crossref record; 352 of the 352 references it cites were found in a registry or an index.
Type 2 diabetes mellitus in adults: pathogenesis, prevention and therapy
Open accessAbstract
Type 2 diabetes (T2D) is a disease characterized by heterogeneously progressive loss of islet β cell insulin secretion usually occurring after the presence of insulin resistance (IR) and it is one component of metabolic syndrome (MS), and we named it metabolic dysfunction syndrome (MDS). The pathogenesis of T2D is not fully understood, with IR and β cell dysfunction playing central roles in its pathophysiology. Dyslipidemia, hyperglycemia, along with other metabolic disorders, results in IR and/or islet β cell dysfunction via some shared pathways, such as inflammation, endoplasmic reticulum stress (ERS), oxidative stress, and ectopic lipid deposition. There is currently no cure for T2D, but it can be prevented or in remission by lifestyle intervention and/or some medication. If prevention fails, holistic and personalized management should be taken as soon as possible through timely detection and diagnosis, considering target organ protection, comorbidities, treatment goals, and other factors in reality. T2D is often accompanied by other components of MDS, such as preobesity/obesity, metabolic dysfunction associated steatotic liver disease, dyslipidemia, which usually occurs before it, and they are considered as the upstream diseases of T2D. It is more appropriate to call “diabetic complications” as “MDS-related target organ damage (TOD)”, since their development involves not only hyperglycemia but also other metabolic disorders of MDS, promoting an up-to-date management philosophy. In this review, we aim to summarize the underlying mechanism, screening, diagnosis, prevention, and treatment of T2D, especially regarding the personalized selection of hypoglycemic agents and holistic management based on the concept of “MDS-related TOD”.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–352 of 352
Sacks, D. B., Arnold, M. A., Bakris, G. L., Bruns, D. E., Horvath, A. R., Lernmark, Å., Metzger, B. E., Nathan, D. M., & Kirkman, M. S. (2023) · Clinical Chemistry · doi:10.1093/clinchem/hvad080 · Cited by 200
Sheu, M. L., Ho, F. M., Yang, R. S., Chao, K. F., Lin, W. W., Lin-Shiau, S. Y., & Liu, S.-H. (2005) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000155462.24263.e4 · Cited by 199
Inhibition of Notch signaling ameliorates insulin resistance in a FoxO1-dependent manner
Pajvani, U. B., Shawber, C. J., Samuel, V. T., Birkenfeld, A. L., Shulman, G. I., Kitajewski, J., & Accili, D. (2011) · Nature Medicine · doi:10.1038/nm.2378 · Cited by 193
Pavlou, V., Cienfuegos, S., Lin, S., Ezpeleta, M., Ready, K. A., Corapi, S., Wu, J. Q., Lopez, J., Gabel, K., Tussing-Humphreys, L. M., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.39337 · Cited by 192
mTORC1 Signaling: A Double-Edged Sword in Diabetic β Cells
Ardestani, A., Lupse, B., Kido, Y., Leibowitz, G., & Maedler, K. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.11.004 · Cited by 190
Integration of Hippo-YAP Signaling with Metabolism
Ibar, C., & Irvine, K. D. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.06.025 · Cited by 185
Pharmacotherapy of type 2 diabetes: An update and future directions
DeMarsilis, A. J., Reddy, N., Boutari, C., Filippaios, A., Sternthal, E., Katsiki, N., & Mantzoros, C. S. (2022) · Metabolism · doi:10.1016/j.metabol.2022.155332 · Cited by 184
Effect of pioglitazone on body composition and energy expenditure: a randomized controlled trial
Smith, S. R., de Jonge, L., Volaufova, J., Li, Y., Xie, H., & Bray, G. A. (2005) · Metabolism · doi:10.1016/j.metabol.2004.07.008 · Cited by 176
Ethnic Variation in Fat and Lean Body Mass and the Association with Insulin Resistance
Lear, S. A., Kohli, S., Bondy, G. P., Tchernof, A., & Sniderman, A. D. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1030 · Cited by 174
Metabolic Communication by SGLT2 Inhibition
Billing, A. M., Kim, Y. C., Gullaksen, S., Schrage, B., Raabe, J., Hutzfeldt, A. D., Demir, F., Kovalenko, E., Lassé, M., Dugourd, A. J. F., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.065517 · Cited by 174
An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage
Wang, Y., Shao, T., Wang, J., Huang, X., Deng, X., Cao, Y., Zhou, M., & Zhao, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110991 · Cited by 173
Yamaguchi, Y., Passeron, T., Hoashi, T., Watabe, H., Rouzaud, F., Yasumoto, K., Hara, T., Tohyama, C., Katayama, I., Miki, T., et al. (2007) · The FASEB Journal · doi:10.1096/fj.07-9475com · Cited by 171
Pajvani, U. B., Qiang, L., Kangsamaksin, T., Kitajewski, J., Ginsberg, H. N., & Accili, D. (2013) · Nature Medicine · doi:10.1038/nm.3259 · Cited by 168
Emerging mechanisms of obesity-associated immune dysfunction
Shaikh, S. R., Beck, M. A., Alwarawrah, Y., & MacIver, N. J. (2024) · Nature Reviews Endocrinology · doi:10.1038/s41574-023-00932-2 · Cited by 168
Rare and Common Genetic Events in Type 2 Diabetes: What Should Biologists Know?
Bonnefond, A., & Froguel, P. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.020 · Cited by 163
Sturek, J. M., Castle, J. D., Trace, A. P., Page, L. C., Castle, A. M., Evans-Molina, C., Parks, J. S., Mirmira, R. G., & Hedrick, C. C. (2010) · Journal of Clinical Investigation · doi:10.1172/jci41280 · Cited by 163
Lachin, J. M., & Nathan, D. M. (2021) · Diabetes Care · doi:10.2337/dc20-3097 · Cited by 163
Speight, J., Holmes‐Truscott, E., Garza, M., Scibilia, R., Wagner, S., Kato, A., Pedrero, V., Deschênes, S. S., Guzman, S., Joiner, K. L., et al. (2023) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(23)00347-9 · Cited by 162
Adolescent Obesity and Early-Onset Type 2 Diabetes
Twig, G., Zucker, I., Afek, A., Cukierman-Yaffe, T., Bendor, C. D., Derazne, E., Lutski, M., Shohat, T., Mosenzon, O., Tzur, D., et al. (2020) · Diabetes Care · doi:10.2337/dc19-1988 · Cited by 161
Hypoxia-inducible factors and diabetes
Gunton, J. E. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137556 · Cited by 159 · cited 1×
“155 Depletion of HIF-1 α shows impaired GSIS, due to the decreased basal and glucose-stimulated ATP concentration 155,156 (Fig.”
BackgroundConversion of Mature Human β-Cells Into Glucagon-Producing α-Cells
Spijker, H. S., Ravelli, R. B. G., Mommaas, A. M., van Apeldoorn, A. A., Engelse, M. A., Zaldumbide, A., Bonner‐Weir, S., Rabelink, T. J., Hoeben, R. C., Clevers, H. C., et al. (2013) · Diabetes · doi:10.2337/db12-1001 · Cited by 159
Maternal inheritance of glucose intolerance via oocyte TET3 insufficiency
Chen, B., Du, Y.-R., Zhu, H., Sun, M.-L., Wang, C., Cheng, Y., Pang, H., Ding, G., Gao, J., Tan, Y., et al. (2022) · Nature · doi:10.1038/s41586-022-04756-4 · Cited by 159
Cholesterol in islet dysfunction and type 2 diabetes
Brunham, L. R., Kruit, J. K., Verchere, C. B., & Hayden, M. R. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33296 · Cited by 158
Chen, L., Liu, B., Ren, L., Du, H., Fei, C., Qian, C., Li, B., Zhang, R., Liu, H., Li, Z., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1069954 · Cited by 155
Self-citationPDX1 is the cornerstone of pancreatic β-cell functions and identity
Ebrahim, N., Shakirova, K. S., & Dashinimaev, E. B. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1091757 · Cited by 152
GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans
Kim, K. S., Park, J. S., Hwang, E., Park, M. J., Shin, H. Y., Lee, Y. H., Kim, K. M., Gautron, L., Godschall, E., Portillo, B., et al. (2024) · Science · doi:10.1126/science.adj2537 · Cited by 148 · cited 1×
“246 In addition, GLP-1 delays gastric emptying and reduces food intake via vagal GLP-1R.”
BackgroundChaurasia, S. S., Lim, R. R., Parikh, B. H., Wey, Y. S., Tun, S. B. B., Wong, T. Y., Luu, C. D., Agrawal, R. V., Ghosh, A., Mortellaro, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-21198-z · Cited by 148
Mutual regulation of metabolic processes and proinflammatory NF-κB signaling
Kracht, M., Müller‐Ladner, U., & Schmitz, M. L. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.07.027 · Cited by 141
Sex-based differences in insulin resistance
Gado, M., Tsaousidou, E., Bornstein, S. R., & Perakakis, N. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0245 · Cited by 138
Villalobos-Labra, R., Subiabre, M., Toledo, F., Pardo, F., & Sobrevía, L. (2018) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2018.11.001 · Cited by 137
Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug
Nesti, L., Tricò, D., Mengozzi, A., & Natali, A. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01294-7 · Cited by 135
Goodall, R. J., Ellauzi, J., Tan, M. K. H., Onida, S., Davies, A. H., & Shalhoub, J. (2020) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2020.03.053 · Cited by 127
Hiramoto, B. A., McCarty, T. R., Lodhia, N. A., Jenkins, A., Elnaiem, A. D., Muftah, M., Flanagan, R. F., & Chan, W. W. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002820 · Cited by 120
Lee, A. K., Lee, C. J., Huang, E. S., Sharrett, A. R., Coresh, J., & Selvin, E. (2017) · Diabetes Care · doi:10.2337/dc17-0819 · Cited by 119
AMPK and the Endocrine Control of Metabolism
Townsend, L. K., & Steinberg, G. R. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad012 · Cited by 119
Petersen, K. F., Dufour, S., Morino, K., Yoo, P. S., Cline, G. W., & Shulman, G. I. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205675109 · Cited by 114
Reciprocal regulation of mTOR complexes in pancreatic islets from humans with type 2 diabetes
Yuan, T., Rafizadeh, S., Gorrepati, K. D. D., Lupše, B., Oberholzer, J., Maedler, K., & Ardestani, A. D. (2016) · Diabetologia · doi:10.1007/s00125-016-4188-9 · Cited by 114
Regulatory Mechanisms of the Wnt/β-Catenin Pathway in Diabetic Cutaneous Ulcers
Zhang, H., Nie, X., Shi, X., Zhao, J., Chen, Y., Yao, Q.-Y., Sun, C., & Yang, J. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01114 · Cited by 108
Podocyte-specific JAK2 overexpression worsens diabetic kidney disease in mice
Zhang, H., Nair, V., Saha, J., Atkins, K. B., Hodgin, J. B., Saunders, T. L., Myers, M. G., Werner, T. B., Kretzler, M., & Brosius, F. C. (2017) · Kidney International · doi:10.1016/j.kint.2017.03.027 · Cited by 107
Lee, C. G., Heckman‐Stoddard, B. M., Dabelea, D., Gadde, K. M., Ehrmann, D. A., Ford, L., Prorok, P. C., Boyko, E. J., Pi-Sunyer, X., Wallia, A., et al. (2021) · Diabetes Care · doi:10.2337/dc21-1046 · Cited by 107
The balance between proinsulin biosynthesis and insulin secretion: where can imbalance lead?
Uchizono, Y., Alarcón, C., Wicksteed, B. L., Marsh, B. J., & Rhodes, C. J. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00774.x · Cited by 104
Yang, H.-L., Tsai, Y., Korivi, M., Chang, C.-T., & Hseu, Y. (2017) · Biochimica et biophysica acta. Molecular cell research · doi:10.1016/j.bbamcr.2016.10.021 · Cited by 103
Montemurro, C., Nomoto, H., Pei, L., Parekh, V. S., Vongbunyong, K. E., Vadrevu, S., Gurlo, T., Butler, A. E., Subramaniam, R., Ritou, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10444-1 · Cited by 103
Tang, C., Koulajian, K., Schuiki, I., Zhang, L., Desai, T. A., Ivovic, A., Wang, P., Robson-Doucette, C. A., Wheeler, M. B., Minassian, B., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2474-8 · Cited by 101
Jabbour, S. A., Frías, J. P., Hardy, E., Ahmed, A., Wang, H., Öhman, P., & Guja, C. (2018) · Diabetes Care · doi:10.2337/dc18-0680 · Cited by 100
Qiao, S., Liu, R., Lv, C., Miao, Y., Yue, M., Tao, Y., Wei, Z., Xia, Y., & Dai, Y. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.09.003 · Cited by 100
What role do fat cells play in pancreatic tissue?
Gerst, F., Wagner, R. J., Oquendo, M. B., Siegel-Axel, D. I., Fritsche, A., Heni, M., Staiger, H., Häring, H., & Ullrich, S. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.05.001 · Cited by 99
Metabolic stress, IAPP and islet amyloid
Montane, J., Klimek‐Abercrombie, A., Potter, K. J., Westwell‐Roper, C., & Bruce Verchere, C. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01657.x · Cited by 98
Gupta, D., Kono, T., & Evans‐Molina, C. (2010) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2010.01299.x · Cited by 97
Lutchman, G. A., Promrat, K., Kleiner, D. E., Heller, T., Ghany, M. G., Yanovski, J. A., Liang, T. J., & Hoofnagle, J. H. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.05.005 · Cited by 94
Roddick, A., Wonnacott, A., Webb, D. R., Watt, A., Watson, M. A., Staplin, N., Riding, A., Lioudaki, E., Kuverji, A., Kossi, M. E., et al. (2023) · BMC Nephrology · doi:10.1186/s12882-023-03339-3 · Cited by 93
Why BMI is flawed — and how to redefine obesity
Prillaman, M. (2023) · Nature · doi:10.1038/d41586-023-03143-x · Cited by 92
Caixeta, D. C., Aguiar, E. M. G., Cardoso-Sousa, L., Coelho, L. M. D., Oliveira, S. W., Espíndola, F. S., Raniero, L. J., Crosara, K. T. B., Baker, M. J., Siqueira, W. L., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0223461 · Cited by 91
Guo, L., Xi, Y., Wenbo, J., Yuan, H., Qin, G., Chen, S., Zhang, L., Liu, Y., Cheng, X., Liu, W., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.16786 · Cited by 91
Impact of non‐alcoholic fatty pancreas disease on glucose metabolism
Yu, T., & Wang, C. (2017) · Journal of Diabetes Investigation · doi:10.1111/jdi.12665 · Cited by 90
Rossing, P. R., Inzucchi, S. E., Vart, P., Jongs, N., Docherty, K. F., Jhund, P. S., Køber, L., Kosiborod, M. N., Martinez, F. A., Ponikowski, P. P., et al. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00295-3 · Cited by 89
Filippatos, T. D., Alexakis, K., Mavrikaki, V., & Mikhailidis, D. P. (2021) · Digestive Diseases and Sciences · doi:10.1007/s10620-021-06824-7 · Cited by 87
Chan, T. T., Tse, Y. K., Lui, R. N.-S., Wong, G. L., Chim, A. M., Kong, A. P. S., Woo, J., Yeung, D. K., Abrigo, J., Chu, C. W., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.09.027 · Cited by 87
Zhang, E., Gao, B., Yang, L., Wu, X., & Wang, Z. (2015) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.115.229369 · Cited by 86
Lee, B., Lee, Y., Park, C., Rhee, E., Lee, W., Kim, N. H., Choi, K. M., Park, K., Choi, Y., Soo, B., et al. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0010 · Cited by 86
Della Pepa, G., Russo, M., Vitale, M., Carli, F., Vetrani, C., Masulli, M., Riccardi, G., Vaccaro, O., Gastaldelli, A., Rivellese, A. A., et al. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108984 · Cited by 84
Kim, E., Kwon, K., Koo, B.-S., Han, M.-J., Song, M., Song, E.-K., Han, M., Park, J., Ryu, D., & Park, B. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.04.005 · Cited by 84
The role of mTOR in the adaptation and failure of β‐cells in type 2 diabetes
Leibowitz, G., Cerasi, E., & Ketzinel‐Gilad, M. (2008) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00952.x · Cited by 81
The complex role of Wnt ligands in type 2 diabetes mellitus and related complications
Nie, X., Wei, X., Ma, H., Fan, L., & Chen, W. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16663 · Cited by 81
Leisure-time and occupational physical activity and health outcomes in cardiovascular disease
Bonekamp, N. E., Visseren, F. L. J., Ruigrok, Y. M., Cramer, M. J., de Borst, G. J., May, A. M., & Koopal, C. (2022) · Heart · doi:10.1136/heartjnl-2022-321474 · Cited by 81
Role of Wnt signaling pathways in type 2 diabetes mellitus
Chen, J., Ning, C., Mu, J., Li, D., Ma, Y., & Meng, X. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04086-5 · Cited by 80
Living Dangerously: Protective and Harmful ER Stress Responses in Pancreatic β-Cells
Sharma, R. B., Landa-Galván, H. V., & Alonso, L. C. (2021) · Diabetes · doi:10.2337/dbi20-0033 · Cited by 80
The Wnt Signaling Pathway in Diabetic Nephropathy
Wang, H., Zhang, R., Wu, X., Chen, Y., Ji, W., Wang, J., Zhang, Y., Xia, Y., Tang, Y., & Yuan, J. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.701547 · Cited by 80
Self-citationContinuous glucose monitoring and intrapersonal variability in fasting glucose
Shilo, S., Keshet, A., Rossman, H., Godneva, A., Talmor‐Barkan, Y., Aviv, Y., & Segal, E. (2024) · Nature Medicine · doi:10.1038/s41591-024-02908-9 · Cited by 78
Transcribing β-cell mitochondria in health and disease
Mulder, H. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.05.014 · Cited by 77
Continuous Glucose Monitoring Profiles in Pregnancies With and Without Gestational Diabetes Mellitus
Durnwald, C. P., Beck, R. W., Li, Z., Norton, E., Bergenstal, R. M., Johnson, M. L., DUNNIGAN, S. M., Banfield, M., KRUMWIEDE, K. J., Sibayan, J., et al. (2024) · Diabetes Care · doi:10.2337/dc23-2149 · Cited by 77
Powers, S. K., & Schrager, M. A. (2022) · Redox Biology · doi:10.1016/j.redox.2022.102374 · Cited by 75
Notch signaling dynamically regulates adult β cell proliferation and maturity
Bartolomé, A., Zhu, C., Sussel, L., & Pajvani, U. B. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98098 · Cited by 73
Time- vs Step-Based Physical Activity Metrics for Health
Hamaya, R., Shiroma, E. J., Moore, C. C., Buring, J. E., Evenson, K. R., & Lee, I.-M. M. (2024) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2024.0892 · Cited by 73
Noninvasive Continuous Monitoring of Tear Glucose Using Glucose‐Sensing Contact Lenses
Ascaso, F. J., & Huerva, V. (2015) · Optometry and Vision Science · doi:10.1097/opx.0000000000000698 · Cited by 72
Genetic and pharmacologic inhibition of ALDH1A3 as a treatment of β-cell failure
Son, J., Du, W. J., Esposito, M., Shariati, K., Ding, H., Kang, Y., & Accili, D. (2023) · Nature Communications · doi:10.1038/s41467-023-36315-4 · Cited by 71
Metformin alleviates renal injury in diabetic rats by inducing Sirt1/FoxO1 autophagic signal axis
Xu, J., Liu, L., Xu, L., Xing, Y., & Ye, S. (2019) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/1440-1681.13226 · Cited by 69
Horne, B. D., Grajower, M. M., & Anderson, J. L. (2020) · JAMA · doi:10.1001/jama.2020.3908 · Cited by 68
Bako, H. Y., Ibrahim, M. A., Isah, M. S., & Ibrahim, S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117045 · Cited by 67
Xu, J., Wu, S., Wang, J., Wang, J., Yan, Y., Zhu, M., Zhang, D., Jiang, C., & Liu, T. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02155-6 · Cited by 67
Yaghi, S. R., Furie, K. L., Viscoli, C. M., Kamel, H., Gorman, M., Dearborn, J. L., Young, L. H., Inzucchi, S. E., Lovejoy, A. M., Kasner, S. E., et al. (2017) · Circulation · doi:10.1161/circulationaha.117.030458 · Cited by 66
Riley, D. R. J., Essa, H., Austin, P. J., Preston, F., Kargbo, I., Hernández, G., Ghuman, R., Cuthbertson, D. J., Lip, G. Y. H., & Alam, U. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15185 · Cited by 66
Research advances in the anti-inflammatory effects of SGLT inhibitors in type 2 diabetes mellitus
Zhang, R., Xie, Q., Lu, X., Fan, R., & Tong, N. (2024) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-024-01325-9 · Cited by 65
Self-citationRIPK3-mediated inflammation is a conserved β cell response to ER stress
Yang, B., Maddison, L. A., Zaborska, K. E., Dai, C., Yin, L., Tang, Z., Zang, L., Jacobson, D. A., Powers, A. C., & Chen, W. (2020) · Science Advances · doi:10.1126/sciadv.abd7272 · Cited by 64
Diabetic Retinopathy: From Animal Models to Cellular Signaling
Pitale, P. M., & Gorbatyuk, M. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031487 · Cited by 64
Sabag, A., Ahmadi, M. N., François, M. E., Postnova, S., Cistulli, P. A., Fontana, L., & Stamatakis, E. (2024) · Diabetes Care · doi:10.2337/dc23-2448 · Cited by 64
Dysfunctions, molecular mechanisms, and therapeutic strategies of pancreatic β-cells in diabetes
Prasad, M. K., Mohandas, S., & Ramkumar, K. M. (2023) · APOPTOSIS · doi:10.1007/s10495-023-01854-0 · Cited by 62
The mTOR promotes oxidative stress-induced apoptosis of mesangial cells in diabetic nephropathy
Lü, Q., Zhou, Y., Hao, M., Li, C., Wang, J., Shu, F., Du, L., Zhu, X., Zhang, Q., & Yin, X. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.12.012 · Cited by 61
Adiponectin Trajectories Before Type 2 Diabetes Diagnosis
Tabák, Á. G., Carstensen, M., Witte, D. R., Brunner, E. J., Shipley, M. J., Jokela, M. M., Roden, M., Mika Kivimaki, B., & Herder, C. (2012) · Diabetes Care · doi:10.2337/dc11-2263 · Cited by 58
Zhang, Y., Han, S., Liu, C., Zheng, Y., Li, H., Gao, F., Bian, Y., Liu, X., Liu, H., Hu, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36680-0 · Cited by 58
Self-citationGarza, K., Aminpour, E., Shah, J., Mehta, B., Early, D., Gyawali, C. P., & Kushnir, V. (2024) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002777 · Cited by 57 · cited 2×
“…period, with evidence suggesting that GLP-1 use increases gastric residue rates and increases the risk of incomplete procedures and aspiration, 248,249 but there is also evidence suggesting that this does not increase the risk of postoperative complications such as postoperative pneumonia.”
Notch signaling in pancreatic endocrine cell and diabetes
Kim, W., Shin, Y., Kim, B.-J., & Egan, J. M. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.12.115 · Cited by 57
Pratley, R. E., Fleck, P. R., & Wilson, C. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12258 · Cited by 56
Zuriaga, M. A., Fuster, J. J., Farb, M. G., MacLauchlan, S., Bretón‐Romero, R., Karki, S., Hess, D. T., Apovian, C. M., Hamburg, N. M., Gokce, N., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17509-5 · Cited by 56
Interleukin 6 Function in the Skin and Isolated Keratinocytes Is Modulated by Hyperglycemia
Lee, E. G., Luckett‐Chastain, L. R., Calhoun, K. N., Frempah, B., Bastian, A., & Gallucci, R. M. (2019) · Journal of Immunology Research · doi:10.1155/2019/5087847 · Cited by 55
Cersosimo, E., Johnson, E. L., Chovanes, C., & Skolnik, N. (2018) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13108 · Cited by 52
Lincoff, A. M., Wolski, K., Nicholls, S. J., & Nissen, S. E. (2007) · JAMA · doi:10.1001/jama.298.10.1180 · Cited by 52
Jiang, Y., Yang, J., Li, X., Wei, T., Cui, X., Wang, D., Jin, Z., Lin, X., Li, F., Yang, K., et al. (2024) · Diabetes · doi:10.2337/db23-0553 · Cited by 51
Zhu, X., Zhao, L., Chen, J., Lin, C., Lv, F., Hu, S., Cai, X., Zhang, L., & Ji, L. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.767152 · Cited by 50
Yao, W., Yang, X., Zhu, J., Gao, B., Shi, H., & Xu, L. (2018) · Scientific Reports · doi:10.1038/s41598-018-20950-9 · Cited by 49
Upregulation of WDR6 drives hepatic de novo lipogenesis in insulin resistance in mice
Yao, Z., Gong, Y., Chen, W., Shao, S., Song, Y., Guo, H., Li, Q., Liu, S., Wang, X., Zhang, Z., et al. (2023) · Nature Metabolism · doi:10.1038/s42255-023-00896-7 · Cited by 48
Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes
Afshinnia, F., Reynolds, E. L., Rajendiran, T. M., Soni, T., Byun, J., Savelieff, M. G., Looker, H. C., Nelson, R. G., Michailidis, G. C., Callaghan, B. C., et al. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51639 · Cited by 47
Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes
Cui, D., Feng, X., Lei, S., Zhang, H., Hu, W., Yang, S., Yu, X., & Su, Z. (2024) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003034 · Cited by 47
MafA Regulation in β-Cells: From Transcriptional to Post-Translational Mechanisms
Liang, J., Chirikjian, M. K., Pajvani, U. B., & Bartolomé, A. (2022) · Biomolecules · doi:10.3390/biom12040535 · Cited by 46
Tian, S., Zhao, H., & Song, H. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2148090 · Cited by 45
Li, X., Xiao, G.-Y., Guo, T., Song, Y., & Li, Q. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.986565 · Cited by 44
Proproliferative and antiapoptotic action of exogenously introduced YAP in pancreatic β cells
Yuan, T., Rafizadeh, S., Azizi, Z., Lupše, B., Gorrepati, K. D. D., Awal, S., Oberholzer, J., Maedler, K., & Ardestani, A. D. (2016) · JCI Insight · doi:10.1172/jci.insight.86326 · Cited by 43
Death versus dedifferentiation: The molecular bases of beta cell mass reduction in type 2 diabetes
Sun, T., & Han, X. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.12.002 · Cited by 43
STAT3 dictates β-cell apoptosis by modulating PTEN in streptozocin-induced hyperglycemia
Weng, Q., Zhao, M., Zheng, J., Yang, L., Xu, Z., Zhang, Z., Wang, J., Wang, J., Yang, B., Lu, Q. R., et al. (2019) · Cell Death and Differentiation · doi:10.1038/s41418-019-0344-3 · Cited by 41
Bouçanova, F., Pollmeier, G., Sándor, K., Morado-Urbina, C. E., Nijssen, J., Médard, J., Bartesaghi, L., Pellerin, L., Svensson, C. I., Hedlund, E., et al. (2020) · Glia · doi:10.1002/glia.23889 · Cited by 40
Rossing, P. R., Inzucchi, S. E., Vart, P., Jongs, N., Docherty, K. F., Jhund, P. S., Køber, L., Kosiborod, M., Martínez, F. A., Ponikowski, P. P., et al. (2022) · UCL Discovery (University College London) · Cited by 40
Geisler, C. E., Ghimire, S., Hepler, C., Miller, K. E., Bruggink, S. M., Kentch, K. P., Higgins, M. R., Banek, C. T., Yoshino, J., Klein, S., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109298 · Cited by 39
Antidiabetic drugs and oxidized low-density lipoprotein: A review of anti-atherosclerotic mechanisms
Ahmadi, A., Panahi, Y., Johnston, T. P., & Sahebkar, A. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105819 · Cited by 39
Endothelial Notch signaling controls insulin transport in muscle
Hasan, S. S., Jabs, M., Taylor, J., Wiedmann, L., Leibing, T., Nordström, V., Federico, G., Roma, L. P., Carlein, C., Wolff, G., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.201809271 · Cited by 38
Shao, M., Chen, D., Wang, Q., Guo, F., Wei, F., Zhang, W., Gan, T., Luo, Y., Fan, X., Du, P., et al. (2024) · Diabetologia · doi:10.1007/s00125-023-06078-0 · Cited by 38
Masson, W., Lavalle-Cobo, A., Lobo, M., Masson, G., & Molinero, G. (2021) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa074 · Cited by 37
He, L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22042121 · Cited by 37
Function of NLRP3 in the Pathogenesis and Development of Diabetic Nephropathy
Fu, Y., Wu, N., & Zhao, D. (2017) · Medical Science Monitor · doi:10.12659/msm.903269 · Cited by 34
Macrophages and neutrophils are necessary for ER stress-induced β cell loss
Yang, B., Yang, L., Wang, Y., Maddison, L. A., Tang, Z., Haigh, S., Gong, Y., Zhang, Y., Covington, B. A., Bosma, K. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111255 · Cited by 33
Self-citationKasperová, B. J., Mráz, M., Svoboda, P., Hlaváček, D., Kratochvílová, H., Módos, I., Vrzáčková, N., Ivák, P., Janovská, P., Kobets, T., et al. (2024) · Cardiovascular Diabetology · doi:10.1186/s12933-024-02298-9 · Cited by 32
Hepatocyte NLRP3 interacts with PKCε to drive hepatic insulin resistance and steatosis
Qin, W., & Weng, J. (2023) · 中国科学通报:英文版 · doi:10.1016/j.scib.2023.06.003 · Cited by 31
Role of endoplasmic reticulum stress in the loss of retinal ganglion cells in diabetic retinopathy.
Yang, L., Wu, L., Wang, D., Li, Y., Dou, H., Tso, M. O. M., & Ma, Z. (2013) · PubMed Central · doi:10.3969/j.issn.1673-5374.2013.33.009 · Cited by 30
Ferrannini, G., Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Díaz, R., Dyal, L., Lakshmanan, M. C., Mellbin, L., Probstfield, J. L., Riddle, M. C., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa777 · Cited by 30
Lim, S. K., Han, K. A., Yu, J., Chamnan, P., Kim, E. S., Yoon, K., Kwon, S. H., Moon, M. K., Lee, K. W., Kim, D., et al. (2016) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12787 · Cited by 29
Wood, N., Straw, S., Cheng, C. W., Hirata, Y., Pereira, M. G., Gallagher, H., Egginton, S., Ogawa, W., Wheatcroft, S. B., Witte, K. K., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3192 · Cited by 29
Mechanism for antioxidative effects of thiazolidinediones in pancreatic β-cells
Chung, S. S., Kim, M., Lee, J. S., Ahn, B. Y., Jung, H. S., Lee, H. M., & Park, K. S. (2011) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00120.2011 · Cited by 28
Liu, W., Zhang, D., Wang, R., Chen, J., Zhang, J., Tao, D., & Liu, C. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15349 · Cited by 28
Clavero‐Jimeno, A., Dote‐Montero, M., Migueles, J. H., Camacho-Cardeñosa, A., Osés, M., Medina, J. E., Alcántara, J. M. A., Muñoz‐Torres, M., Labayen, I., & Ruiz, J. R. (2024) · Obesity · doi:10.1002/oby.24063 · Cited by 28
Dorkhan, M., Dencker, M., Stagmo, M., & Groop, L. (2009) · Cardiovascular Diabetology · doi:10.1186/1475-2840-8-15 · Cited by 27
Emerging Role of Protein O-GlcNAcylation in Liver Metabolism: Implications for Diabetes and NAFLD
Xie, Z., Xie, T., Liu, J., Zhang, Q., & Xiao, X. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032142 · Cited by 25
Ataie-Ashtiani, S., & Forbes, B. E. (2023) · Cells · doi:10.3390/cells12071008 · Cited by 25
Alatas, F. S., Matsuura, T., Pudjiadi, A. H., Wijaya, S., & Taguchi, T. (2020) · Pediatric Gastroenterology Hepatology & Nutrition · doi:10.5223/pghn.2020.23.4.346 · Cited by 24
Liu, Y., Li, J., Wu, Y., Zhang, H., Lv, Q., Zhang, Y., Zheng, X., & Tong, N. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.835460 · Cited by 23
Self-citationEffects of c-MYC activation on glucose stimulus-secretion coupling events in mouse pancreatic islets
Pascal, S., Guiot, Y., Pelengaris, S., Khan, M., & Jonas, J. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90235.2008 · Cited by 22
Bhat, O. M., Kumar, P. U., Harishankar, N., Ravichandaran, L., Bhatia, A., & Dhawan, V. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2922-8 · Cited by 22
MicroRNA‐7a‐5p ameliorates diabetic peripheral neuropathy by regulating VDAC1/JNK/c‐JUN pathway
Jiao, Y., Zhang, Y., Wang, C., Yu, Y., Li, Y., Cui, W., Li, Q., & Yu, Y. (2022) · Diabetic Medicine · doi:10.1111/dme.14890 · Cited by 22
Self-citationBowen, A., Kos, K., Whatmore, J. L., Richardson, S. J., & Welters, H. J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.130 · Cited by 20
Samadi, M., Aziz, S. G., & Naderi, R. (2020) · Cell Stress and Chaperones · doi:10.1007/s12192-020-01170-5 · Cited by 20
The novel amyloid-beta peptide aptamer inhibits intracellular amyloid-beta peptide toxicity
Yang, Y., Wu, J., Wang, X., Yang, Y., Jia, M., Ma, C., Wang, M., & Che, L. (2013) · Neural Regeneration Research · doi:10.4103/1673-5374.126979 · Cited by 20
Wang, S., Cai, Y., Bu, R., Wang, Y., Lin, Q., Chen, Y., & Wu, C. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01137-0 · Cited by 19
mTOR Signaling: New Insights into Cancer, Cardiovascular Diseases, Diabetes and Aging
Das, A., & Reis, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241713628 · Cited by 16
Welk, B., McClure, J. A., Carter, B., Clarke, C., Dubois, L., & Clemens, K. K. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15711 · Cited by 16
Notch-mediated Ephrin signaling disrupts islet architecture and β cell function
Bartolomé, A., Suda, N., Yu, J., Zhu, C., Son, J., Ding, H., Califano, A., Accili, D., & Pajvani, U. B. (2022) · JCI Insight · doi:10.1172/jci.insight.157694 · Cited by 15
Xu, C., Li, H., Xu, Q., Zhao, K., Hao, M., Lin, W., Ma, X., Gao, X., & Kuang, H. (2023) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2023.108631 · Cited by 15
Garvey, W. T., Cohen, R. M., Butera, N. M., Kazemi, E. J., Younes, N., Rosin, S. P., Suratt, C. E., Ahmann, A., Hollander, P. A., Krakoff, J. A., et al. (2024) · Diabetes Care · doi:10.2337/dc23-1782 · Cited by 15
PPARγ Mediates Protective Effect against Hepatic Ischemia/Reperfusion Injury via NF-κB Pathway
Liu, X., Zhang, P., Song, X.-Q., Cui, H., & Shen, W. (2022) · Journal of Investigative Surgery · doi:10.1080/08941939.2022.2090033 · Cited by 14
Kirkpatrick, C. F., Liday, C., & Maki, K. C. (2020) · Current Atherosclerosis Reports · doi:10.1007/s11883-020-00838-8 · Cited by 12
Liu, M., Zhang, Y., Zhang, Y., He, P., Zhou, C., Ye, Z., Yang, S., Gan, X., Hou, F. F., & Qin, X. (2024) · British Journal of Sports Medicine · doi:10.1136/bjsports-2023-107564 · Cited by 12
Self-citationXu, S., Wu, Y., Li, J., Pan, X., Zhang, X., Liu, Y., Zhang, F., & Tong, N. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1821234 · Cited by 8
Self-citationZhang, F., Ji, L., Hong, T., Guo, L., Li, Y., Zhu, Z., Liu, X., Liu, F., Tang, L., Zhang, Y., et al. (2022) · Journal of Evidence-Based Medicine · doi:10.1111/jebm.12474 · Cited by 8
Self-citationProtective effects and mechanisms of dapagliflozin on renal ischemia/reperfusion injury
Qiuxiao-Zhu, Huiyao-Hao, Li, N., Zibo-Liu, Wang, Q., Linyi-Shu, & Lihui-Zhang (2024) · Transplant Immunology · doi:10.1016/j.trim.2024.102010 · Cited by 7
Xie, Q., Pan, X., Zhang, X., Ma, J., Peng, G., & Tong, N. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002778 · Cited by 3
Self-citation
Cited by
Obesity: pathophysiology and therapeutic interventions
Kong, Y., Yang, H., Nie, R., Zhang, X., Zuo, F., Zhang, H., & Nian, X. (2025) · Molecular Biomedicine · doi:10.1186/s43556-025-00264-9 · Cited by 89
Self-citationBajaj, H. S., Welch, M., Shah, P., Luna, E., Jaouimaa, F.-Z., Liu, B., Liu, R., Chen, Y., Patel, H., & Bartee, A. (2026) · The Lancet · doi:10.1016/s0140-6736(26)00967-0 · Cited by 23
García-Niño, W. R., Zúñiga-Muñoz, A. M., & Maldonado-Macías, X. P. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178715 · Cited by 1
Metadata
- Authors
- Lu, X., Xie, Q., Pan, X., Zhang, R., Zhang, X., Peng, G., Zhang, Y., Shen, S., & Tong, N.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2024-10-02
- Volume
- 9
- Issue
- 1
- Pages
- 262-262
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W4403013111
- Cited by
- 665
- References
- 352
- FWCI
- 180.45
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.